The Serine/Threonine Protein Kinase Pim pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase Pim targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Serine/Threonine Protein Kinase Pim pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Immunology, Gastrointestinal, and Infectious Disease which include the indications Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Diffuse Large B-Cell Lymphoma, Psoriasis, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Coronavirus Disease 2019 (COVID-19). It also reviews key players involved in Serine/Threonine Protein Kinase Pim targeted therapeutics development with respective active and dormant or discontinued products.
The Serine/Threonine Protein Kinase Pim pipeline targets constitutes close to 23 molecules. Out of which, approximately 19 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, Preclinical, and Discovery stages are 2, 3, 12, and 2 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 2, and 2 molecule.
Serine/Threonine Protein Kinase Pim overview
Serine/threonine protein kinase Pim-1 is a serine/threonine kinase proto-oncogene that is part of the calcium/calmodulin-regulated kinases (CAMK) group. Pim-1 is overexpressed in a range of hematopoietic malignancies and solid cancers. Pim-1 is an enzyme that in humans is encoded by the PIM1 gene.
For a complete picture of Serine/Threonine Protein Kinase Pim’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.